• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Kadcyla

Pharma

Daiichi Sankyo dials up Enhertu projection

Daiichi Sankyo now expects Enhertu could reach JPY 195.2 billion ($1.31 billion) sales in FY2022, a big increase from the previous JPY 128.4 billion.
Angus Liu Oct 31, 2022 12:17pm

AZ, Daiichi's Enhertu, after 2 recent nods, notches trial win

Aug 15, 2022 11:45am

AZ, Daiichi's Enhertu leaps into 2L breast cancer

May 5, 2022 7:55am

Seagen undaunted by AstraZeneca-Daiichi's Enhertu

Oct 29, 2021 3:32pm

AZ-Daiichi, Biogen-Samsung, Clover and more—Fierce Pharma Asia

Sep 24, 2021 8:45am

Enhertu delivers massive progression edge over Kadcyla

Sep 18, 2021 9:05am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy